AAAAAA

   
Results: 1-14 |
Results: 14
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Schreij, G van der Geest, S Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals, J ACQ IMM D, 27(4), 2001, pp. 344-349
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Hoetelmans, RMW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine, THER DRUG M, 23(6), 2001, pp. 606-611
Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Beijnen, JH Lange, JMA Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine, THER DRUG M, 23(3), 2001, pp. 255-258
The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons
Authors: Veldkamp, AI Harris, M Montaner, JSG Moyle, G Gazzard, B Youle, M Johnson, M Kwakkelstein, MO Carlier, H van Leeuwen, R Beijnen, JH Lange, JMA Reiss, P Hoetelmans, RMW
Citation: Ai. Veldkamp et al., The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons, J INFEC DIS, 184(1), 2001, pp. 37-42
Nevirapine plus didanosine: Once or twice daily combination?
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Reiss, P Lange, JMA Kwakkelstein, MO Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Nevirapine plus didanosine: Once or twice daily combination?, J ACQ IMM D, 25(1), 2000, pp. 93-95
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study, AIDS, 14(9), 2000, pp. F103-F110
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Lange, JMA Danner, SA Foudraine, NA Kwakkelstein, MO Reiss, P Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals, AIDS, 14(8), 2000, pp. F77-F82
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir
Authors: Koks, CHW van Heeswijk, RPG Veldkamp, AI Meenhorst, PL Mulder, JW van der Meer, JTM Beijnen, JH Hoetelmans, RMW
Citation: Chw. Koks et al., Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir, AIDS, 14(1), 2000, pp. 89-90
Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
Authors: Veldkamp, AI Sparidans, RW Hoetelmans, RMW Beijnen, JH
Citation: Ai. Veldkamp et al., Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 736(1-2), 1999, pp. 123-128
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
Authors: Veldkamp, AI van Heeswijk, RPG Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 734(1), 1999, pp. 55-61
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection
Authors: Veldkamp, AI van Heeswijk, RPG Hoetelmans, RMW Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection, J CHROMAT B, 727(1-2), 1999, pp. 151-157
Ritonavir enables combined therapy with rifampin and saquinavir
Authors: Veldkamp, AI Hoetelmans, RMW Beijnen, JH Mulder, JW Meenhorst, PL
Citation: Ai. Veldkamp et al., Ritonavir enables combined therapy with rifampin and saquinavir, CLIN INF D, 29(6), 1999, pp. 1586-1586
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Hoetelmans, RMW Mulder, JW Schreij, G Hsu, A Lange, JMA Beijnen, JH Meenhorst, PL
Citation: Rpg. Van Heeswijk et al., The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals, AIDS, 13(14), 1999, pp. F95-F99
Risultati: 1-14 |